Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
Morgan Stanley Upgrades LifeStance Health Gr to Overweight, Announces $8 Price Target
Morgan Stanley analyst Ricky Goldwasser upgrades LifeStance Health Gr (NASDAQ:LFST) from Equal-Weight to Overweight and announces $8 price target.
BTIG Upgrades Borr Drilling to Buy
BTIG analyst Gregory Lewis upgrades Borr Drilling (NYSE:BORR) from Neutral to Buy.
Benchmark Upgrades Western Digital to Hold
Benchmark analyst Mark Miller upgrades Western Digital (NASDAQ:WDC) from Sell to Hold.
Wells Fargo Upgrades SunPower to Equal-Weight, Announces $21 Price Target
Wells Fargo analyst Michael Blum upgrades SunPower (NASDAQ:SPWR) from Underweight to Equal-Weight and announces $21 price target.
Wells Fargo Upgrades Stitch Fix to Equal-Weight, Announces $4 Price Target
Wells Fargo analyst Ike Boruchow upgrades Stitch Fix (NASDAQ:SFIX) from Underweight to Equal-Weight and announces $4 price target.
Cowen & Co. Upgrades Molson Coors Beverage to Outperform, Raises Price Target to $60
Cowen & Co. analyst Vivien Azer upgrades Molson Coors Beverage (NYSE:TAP) from Market Perform to Outperform and raises the price target from $55 to $60.
Wells Fargo Upgrades Sunrun to Overweight, Announces $32 Price Target
Wells Fargo analyst Michael Blum upgrades Sunrun (NASDAQ:RUN) from Equal-Weight to Overweight and announces $32 price target.
Jefferies Upgrades Aligos Therapeutics to Buy, Raises Price Target to $3
Jefferies analyst Michael Yee upgrades Aligos Therapeutics (NASDAQ:ALGS) from Hold to Buy and raises the price target from $2.5 to $3.
Jefferies Upgrades Amarin Corp to Buy, Raises Price Target to $3
Jefferies analyst Michael Yee upgrades Amarin Corp (NASDAQ:AMRN) from Hold to Buy and raises the price target from $1.3 to $3.